Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Despite rising procedure volumes, driven by the country's growing elderly arthritic population, the Japanese large-joint reconstructive implant market will see only marginal growth over the forecast period. Falling ASPs—reflecting biennial MHLW reimbursement cuts, price competition, and the slower entry and adoption of premium-priced devices relative to other mature markets globally—will largely offset the impact of procedural expansion on overall market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for reconstructive joint implants in Japan across a 10-year period.
Biennial MHLW reimbursement cuts will continue to negatively affect the Japanese large-joint reconstructive implant market.
Which segments will be most severely impacted by the MHLW reimbursement cuts?
To what degree will reimbursement cuts be compounded by market competition?
The uptake of technological advances in large-joint reconstructive surgery techniques and products, such as robotic-assisted reconstructive knee implant surgery, is hindered by high barriers to entry in the Japanese market.
How will advances in large-joint reconstructive implant surgical techniques impact the Japanese market?
Which innovations will see the strongest adoption in Japan?
MNCs dominate the Japanese large-joint reconstructive implant market.
Which MNCs have the strongest presence in the Japanese market?
What strategies and factors will contribute to success in this region through 2027?
Already a Client? Log in to access this report.
Meenu Sankar is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde. Follow Meenu on Twitter:@meenu_sankarDRG